The objective of the present study was to investigate whether double intra-vulvo submucosal administration of prostaglandin F2α (PGF2α) could improve farrowing synchronization compared to single administration, and the effects of the induction of farrowing on colostrum yield and piglet performances. In total, 91 sows were randomly assigned to one of three groups: i) treatment with a single or ii) double administration of PGF2α or iii) control group without any treatment. A synthetic analogue of PGF2α was administrated via the intra-vulvo submucosal route on day 114 of gestation, at 0800 hr (single administration) or at 0800 and 1400 hr (double administration). The animals were monitored during the farrowing process. The time interval from the first administration of PGF2α to the onset of parturition was compared between groups. The proportion of sows that farrowed within 32 hr of induced parturition was higher in the double administration group than in the single administration group (100 vs. 84.4%, P=0.046). The duration of farrowing was higher in single administration sows than in control (241.1 vs. 169.5 min, P=0.004) and tended to be higher than in double administration sows (241.1 vs. 190.3 min, P=0.088). Birth interval of piglets born after double administration of PGF2α was shorter than those born after a single administration (14.6 and 20.1 min, P=0.024). In sows, the induction of parturition using a double administration of PGF2α reduces variation in gestation length and significantly increases the proportion of sows with an early response to PGF2α.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6785605PMC
http://dx.doi.org/10.1292/jvms.18-0725DOI Listing

Publication Analysis

Top Keywords

double administration
28
single administration
20
administration pgf2α
16
administration
14
induction parturition
8
double
8
parturition double
8
administration prostaglandin
8
prostaglandin f2α
8
reduces variation
8

Similar Publications

Objective: To explore the impact of perioperative intravenous (IV) paracetamol, administered with caudal ropivacaine on the quality of postoperative recovery in children undergoing hypospadias repair.

Study Design: Double-blinded randomised controlled trial. Place and Duration of the Study: The operating room, post-anaesthesia care unit (PACU), and paediatric surgical ward at the Aga Khan University Hospital, from 31st January 2019 to 1st May 2022.

View Article and Find Full Text PDF

Background: Surgical intervention is critical in the treatment of hip developmental dysplasia in children. Perioperative analgesia, usually based on high opioid dosages, is frequently used in these patients. In some circumstances, regional anesthetic procedures such as caudal block and lumbar plexus block have also been used.

View Article and Find Full Text PDF

Insomnia and some insomnia treatments can impact an individual's daytime functioning. Here, we performed post hoc analyses of patient-reported outcomes from a phase 3 clinical trial to assess the impact of lemborexant (LEM), a dual orexin receptor antagonist, on daytime functioning. Adults with insomnia were randomized 1:1:1 to receive placebo, LEM 5 mg (LEM5) or LEM 10 mg (LEM10) for 6 months.

View Article and Find Full Text PDF

Introduction: Esketamine has unique advantages in combination with dexmedetomidine for sedation in young children, owing to its sympathetic activity and mild respiratory depression. However, the optimal dose is yet to be determined. In this study, we compared the different doses of intranasal esketamine combined with dexmedetomidine for sedation during transthoracic echocardiography in toddlers.

View Article and Find Full Text PDF

This study aimed to assess the efficacy and safety of a combination therapy of Allisartan Isoproxil 240 mg and Amlodipine 5 mg (ALI/AML) compared to AML 5 mg monotherapy in patients with mild-to-moderate essential hypertension. In this phase III, multicenter, double-blind, parallel-group, randomized controlled trial, patients aged 18-70 years with mean sitting systolic blood pressure (msSBP) between 140 and <180 mmHg and mean sitting diastolic blood pressure (msDBP) between 90 and <110 mmHg, following a 4-week treatment with AML 5 mg, were randomized 1:1 to receive either ALI/AML or AML once daily for 12 weeks. This 12-week double-blind period was followed by an open-label extension of ALI/AML treatment through week 52.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!